-- Haisco Pharmaceutical's (SHE:002653) net profit attributable to shareholders in 2025 fell 34% year on year to 259.6 million yuan, or 0.23 yuan per share, according to a Shenzhen bourse filing on Monday.
The attributable profit a year earlier was 395.5 million yuan, or 0.35 yuan per share.
Operating revenue rose 18% to 4.39 billion yuan from 3.72 billion yuan in the previous year.
The pharmaceutical company's shares jumped less than 3% during the midday trade.